Finance

Lists
SAN:EPA
Sanofi SA
၇၂.၆၄ €
+၁.၆၄%
(+၁.၁၇) 1D
စက် ၃၀, GMT+၂ ၁၇:၃၆:၄၈  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for SAN...
Open
၇၁.၇၆ €
High
၇၂.၈၇ €
Low
၇၁.၄၇ €
Mkt. cap
ဋေ ၈.၇၇ ထ
Avg. vol.
၁.၇၈ သန်း
Volume
၃.၀၆ သန်း
P/E ratio
၂၂.၂၈
52-wk high
၉၁.၁၅ €
52-wk low
၇၀.၉၆ €
EPS
၃.၂၆ €
Shares outstanding
၁၂၀.၇၈ ဋေ
No. of employees
၇ သောင်း
Open
၇၁.၇၆ €
High
၇၂.၈၇ €
Low
၇၁.၄၇ €
Mkt. cap
ဋေ ၈.၇၇ ထ
Avg. vol.
၁.၇၈ သန်း
Volume
၃.၀၆ သန်း
P/E ratio
၂၂.၂၈
52-wk high
၉၁.၁၅ €
52-wk low
၇၀.၉၆ €
EPS
၃.၂၆ €
Shares outstanding
၁၂၀.၇၈ ဋေ
No. of employees
၇ သောင်း
News stories
From web sources and news partners
TipRanks
TipRanks
·
ပြီးခဲ့သည့် ၂၃ နာရီ
Sanofi’s Teplizumab Study Signals a New Front in Pediatric Type 1 Diabetes
AD HOC NEWS
AD HOC NEWS
·
ပြီးခဲ့သည့် ၂၃ နာရီ
Sanofi stock after-hours at EUR 71.50: minus 1.27 percent versus prior close
The Globe and Mail
The Globe and Mail
·
ပြီးခဲ့သည့် ၁ ရက်
GSK vs. SNY: Which Europe-Based Pharma Stock Has More Potential?
Profile
Sanofi S.A. is a French multinational pharmaceutical and healthcare company headquartered in Paris. The corporation was established in 1973 and merged with Synthélabo in 1999 to form Sanofi-Synthélabo. In 2004, Sanofi-Synthélabo merged with Aventis and renamed to Sanofi-Aventis, which were each the product of several previous mergers. It changed its name back to Sanofi in May 2011. The company trades as "SAN" on Euronext Paris and "SNY" on Nasdaq in the United States, and is a component of the Euro Stoxx 50 stock market index. In 2023, the company was ranked 89th in the Forbes Global 2000. Sanofi engages in the research and development, manufacturing, and marketing of pharmacological products, principally in the prescription market, but the firm also develops over-the-counter medications. The corporation covers seven major therapeutic areas: cardiovascular, central nervous system, diabetes, internal medicine, oncology, thrombosis, and vaccines. It is one of the world's largest producer of vaccines through its subsidiary Sanofi Pasteur. Wikipedia
About Sanofi SA
CEOPaul Hudson | Belén Garijo
Employees၇.၄၈ သောင်း
Founded၁၉၇၃
Headquartersပါရီမြို့, Île-de-France, ပြင်သစ်
Sector-
Websitesanofi.com
Last report
၂၀၂၆ ဇူ ၃၀
Fiscal period
Q2 2026
EPS / Est. (EUR)
- / ၁.၉၀ €
Revenue / Est. (EUR)
ဋေ ၁.၂၃ ထ / ဋေ ၁.၀၉ ထ
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in EUR
Loading Previous Earnings...
Revenue
Net income
All values in EUR
၂၀၂၅ စက်
၂၀၂၅ ဒီ
၂၀၂၆ မတ်
၂၀၂၆ ဇွန်
Revenue
ဋေ ၁.၃၂ ထ
ဋေ ၁.၂၂ ထ
ဋေ ၁.၁၂ ထ
ဋေ ၁.၂၃ ထ
Cost of goods sold
၃၄၁.၂၀ ဋေ
၃၆၃.၀၀ ဋေ
၃၀၅.၆၀ ဋေ
၂၈၈.၉၀ ဋေ
Cost of revenue
၃၄၁.၂၀ ဋေ
၃၆၃.၀၀ ဋေ
၃၀၅.၆၀ ဋေ
၂၈၈.၉၀ ဋေ
Research and development expenses
၁၈၃.၄၀ ဋေ
၂၂၉.၁၀ ဋေ
၁၇၄.၇၀ ဋေ
၂၂၃.၃၀ ဋေ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
၂၂၉.၁၀ ဋေ
၂၈၁.၉၀ ဋေ
၂၃၂.၇၀ ဋေ
၂၄၉.၂၀ ဋေ
Operating expense
၅၉၇.၄၀ ဋေ
၆၈၃.၅၀ ဋေ
၅၉၃.၉၀ ဋေ
၆၈၂.၄၀ ဋေ
Total operating expenses
၉၃၈.၆၀ ဋေ
ဋေ ၁.၀၅ ထ
၈၉၉.၅၀ ဋေ
၉၇၁.၃၀ ဋေ
Operating income
၃၇၈.၄၀ ဋေ
၁၇၄.၀၀ ဋေ
၂၂၄.၉၀ ဋေ
၂၅၈.၇၀ ဋေ
Other non operating income
-
၁၂.၂၀ ကုဋေ
-၄.၀၀ ကုဋေ
-၉.၁၀ ကုဋေ
EBT including unusual items
၃၅၀.၈၀ ဋေ
-၁၁၅.၅၀ ဋေ
၂၀၁.၄၀ ဋေ
၈၂.၈၀ ကုဋေ
EBT excluding unusual items
၃၆၆.၉၀ ဋေ
၁၇၀.၅၀ ဋေ
၂၁၄.၂၀ ဋေ
၂၃၉.၅၀ ဋေ
Income tax expense
၆၈.၀၀ ကုဋေ
-၃၄.၈၀ ကုဋေ
၄၂.၀၀ ကုဋေ
၄၅.၁၀ ကုဋေ
Effective tax rate
၁၉.၃၈%
၃၀.၁၃%
၂၀.၈၅%
၅၄.၄၇%
Other operating expenses
၁၃၈.၈၀ ဋေ
၁၁၈.၇၀ ဋေ
၁၃၃.၀၀ ဋေ
၁၅၄.၇၀ ဋေ
Net income
၂၈၀.၂၀ ဋေ
-၈၀.၁၀ ကုဋေ
၁၆၁.၄၀ ဋေ
၃၄.၃၀ ကုဋေ
Net profit margin
၂၁.၂၈%
-၆.၅၆%
၁၄.၃၅%
၂.၇၉%
Earnings per share
-
၁.၅၃
၁.၈၈
-
Interest and investment income
၁၁.၄၀ ကုဋေ
၇.၉၀ ကုဋေ
၆.၀၀ ကုဋေ
၆.၄၀ ကုဋေ
Interest expense
-၂၂.၇၀ ကုဋေ
-
-၁၃.၈၀ ကုဋေ
-၁၅.၃၀ ကုဋေ
Net interest expenses
-၁၁.၃၀ ကုဋေ
၇.၉၀ ကုဋေ
-၇.၈၀ ကုဋေ
-၈.၉၀ ကုဋေ
Depreciation and amortization charges
-
-
-
-
EBITDA
၄၁၉.၆၇ ဋေ
၃၄၉.၀၀ ဋေ
၂၇၈.၄၀ ဋေ
၃၈၂.၆၀ ဋေ
Gain or loss from assets sale
၂၆.၆၀ ကုဋေ
-၇.၉၀ ကုဋေ
-
-၉.၀၀ သန်း
AI content may include mistakes. Learn more
Google အက်ပ်များ